Effects of sustained-release atorvastatin calcium nanofiber scaffold on cell adhesion and proliferation

doi:10.3969/j.issn.2095-4344.2310

Abstract

Abstract:

BACKGROUND: Statins plays a significant role in regulating blood lipids, treating and preventing cardiovascular and cerebrovascular diseases. Studies have shown that statins has certain potential in promoting bone formation and treating osteoporosis.

OBJECTIVE: To prepare the drug release scaffolds for the sustained release of atorvastatin calcium, which consist of bovine serum albumin microspheres and polycaprolactone electrostatic spinning fibers, and to investigate the effects of the drug sustained release scaffolds on osteoblast adhesion and proliferation.

METHODS: Bovine serum albumin microspheres containing atorvastatin calcium were prepared by desolvation. A layer of chitosan was coated on the surface of the bovine serum albumin microspheres by electrostatic adsorption, which can increase the stability of the microspheres. Bovine serum albumin microspheres were purified and lyophilized for later use. The lyophilized powder of microspheres was dissolved in organic solvent. An appropriate amount of hydroxyapatite was added in the solvent. The nanofiber scaffolds for sustained release of atorvastatin calcium were prepared via electrospinning. The micromorphology, degradation performance, and sustained-release performance of the nanofiber scaffolds were characterized. The prepared nanofiber scaffolds for sustained-release of atorvastatin calcium were co-cultured with MC3T3-E1 cells to observe cell adhesion and proliferation.

RESULTS AND CONCLUSION: (1) Transmission electron microscopy revealed that the shape of the bovine serum albumin nanospheres was regular and circular. Bovine serum albumin nanospheres were discarded in the electrostatic spinning fibers. The basic morphology of the microspheres was retained. (2) Scanning electron microscopy revealed that the nanofibers used for preparation of nanofiber scaffolds for sustained-release of atorvastatin calcium were composed of filaments with uniform diameters and continuous smooth surface. Filaments were intertwined to form a network structure. (3) The nanofiber scaffolds exhibited the fastest degradation in the first month. The material was incomplete when degraded for 3 months. (4) The nanofiber scaffolds had the ability to slow down the release of drugs. The effect could last for more than 1 month. The overall process of drug release was similar to the zero-order kinetic process. (5) The nanofiber scaffolds for sustained-release of atorvastatin calcium can promote MC3T3-E1 cell adhesion and proliferation. (6) These results suggest that the nanofiber scaffolds for sustained-release of atorvastatin calcium have good biocompatibility and can promote the adhesion and proliferation of osteoblasts.

Key words: drug sustained-release, electrostatic spinning fibers, atorvastatin calcium, polycaprolactone, microspheres, scaffold, cell proliferation

CLC Number:

Wang Le, Hui Min, Dong Xiling, Zhou Han, Dong Hongliang, Zhang Xiaoming, Liu Tongbin. Effects of sustained-release atorvastatin calcium nanofiber scaffold on cell adhesion and proliferation[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(28): 4492-4497.

Figures/Tables 7

References

[1] 李莺,尤亚鹏,李宝娥,等.纯钛表面TiO_2纳米管结合Ⅰ型胶原促进成骨细胞黏附和骨结合[J].中国组织工程研究,2019,23(14): 2169-2176.

[2] 杨玉鹏,赵海静,谷建琦,等.钛芯与骨形成蛋白复合材料修复即刻种植牙槽骨缺陷的评价[J].中国组织工程研究,2017,21(22): 3536-3540.

[3] SEVIMAY M, TURHAN F, KILIÇARSLAN MA, et al. Three-dimensional finite element analysis of the effect of different bone quality on stress distribution in an implant-supported crown.J Prosthet Dent. 2005;93(3): 227-234.

[4] LEE S, GANTES B, RIGGS M, et al. Bone density assessments of dental implant sites: 3. Bone quality evaluation during osteotomy and implant placement.Int J Oral Maxillofac Implants.2007;22(2):208-212.

[5] OFFERMANNS V, ZOFFMANN ANDERSEN O, RIEDE G, et al. Bone regenerating effect of surface-functionalized titanium implants with sustained-release characteristics of strontium in ovariectomized rats.Int J Nanomed.2016;11:2431-2442.

[6] CORCUERA-FLORES JR, ALONSO-DOMÍNGUEZ AM, SERRERA-FIGALLO MÁ, et al. Relationship Between Osteoporosis and Marginal Bone Loss in Osseointegrated Implants: A 2-Year Retrospective Study. J Periodontol. 2016; 87(1):14-20.

[7] WANG M, LAN L, LI T, et al. The effect of oxytocin on osseointegration of titanium implant in ovariectomized rats. Connect Tissue Res.2016;57(3):220-225.

[8] SANTOS PL,GULINELLI JL, TELLES CS, et al. Bone substitutes for peri-implant defects of postextraction implants. Int J Biomater.2013;2013:307136.

[9] WANG Z, LI Y, ZHOU F, et al. Effects of Statins on Bone Mineral Density and Fracture Risk. Medicine. 2016;95(22):e3042.

[10] TSARTSALIS AN, DOKOS C, KAIAFA GD, et al. Statins, bone formation and osteoporosis: hope or hype?Hormones(Athens, Greece).2012;11(2):126.

[11] ORYAN A, ALIDADI S, MOSHIRI A, et al. Bone regenerative medicine: classic options, novel strategies, and future directions. J Orthop Surg Res.2014;9(1):18.

[12] GUTIERREZ GE, LALKA D, GARRETT IR, et al. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations.Osteoporosis Int. 2006;17(7):1033-1042.

[13] ZHENG IC, LI CC. Multiblock copolymers composed of poly (butylenes succinate)and poly(1,2-propylenesuccinate): Effect of molar ratio of diisocyanate to polyester diols oncrosslink densities, thermal properties, mechanical properties and biodegradability.Polym Degrad Stabil. 2010; 9(95):1-8.

[14] ZENG JB, LI YD. A novel biodegradable multiblock poly(ester urethane)containing poly(L-lactic acid)and poly(butylene sue-cinate)blocks.Polymer.2009;(50):1178-1186.

[15] DASH TK, KONKIMALLA VB. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review. J Control Release.2012;158(1):15-33.

[16] YOSHIMOTO H, SHIN YM, TERAI H, et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering.Biomaterials.2003;24(12):2077-2082.

[17] EICHHORN SJ, SAMPSON WW. Statistical geometry of pores and statistics of porous nanofibrous assemblies.J R Soc Interface.2005;2(4):309-318.

[18] FU R, LI C, YU C, et al. A novel electrospun membrane based on moxifloxacin hydrochloride/poly(vinyl alcohol)/sodium alginate for antibacterial wound dressings in practical application. Drug Delivery.2014;23(3):818-829.

[19] WENG L, XIE J. Smart electrospun nanofibers for controlled drug release: recent advances and new perspectives.Curr Pharm Design.2015;21(15):1944.

[20] HAN D, STECKL AJ. Triaxial Electrospun Nanofiber Membranes for Controlled Dual Release of Functional Molecules.ACS Appl Mater Inter.2013;5(16):8241-8245.

[21] WADE RJ, BASSIN EJ, GRAMLICH WM, et al. Nanofibrous Hydrogels with Spatially Patterned Biochemical Signals to Control Cell Behavior.Adv Mater.2015;27(8):1356-1362.

[22] SANTANA-MELO GF, RODRIGUES BVM, DA SILVA E, et al. Electrospun ultrathin PBAT/nHAp fibers influenced the in vitro and in vivo osteogenesis and improved the mechanical properties of neoformed bone.Colloid Surface B. 2017;155: 544-552.

[23] LI L, ZHOU G, WANG Y, et al. Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect.Biomaterials.2015;37:218-229.

[24] LI D, SUN H, JIANG L, et al. Enhanced Biocompatibility of PLGA Nanofibers with Gelatin/Nano-Hydroxyapatite Bone Biomimetics Incorporation.ACS Appl Mater Inter. 2014;6(12): 9402-9410.

[25] WANG J, SUN B, TIAN L, et al. Evaluation of the potential of rhTGF- β3 encapsulated P(LLA-CL)/collagen nanofibers for tracheal cartilage regeneration using mesenchymal stems cells derived from Wharton's jelly of human umbilical cord[J]. Mat Sci Eng C.2017;70:637-645.

[26] ZHANG X, REAGAN MR, KAPLAN DL. Electrospun silk biomaterial scaffolds for regenerative medicine.Adv Drug Deliver Rev.2009;61(12):988-1006.

[27] KIM K, LUU YK, CHANG C, et al. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds.J Control Release.2004;98(1):47-56.

[28] KHALF A, SINGARAPU K, MADIHALLY SV. Influence of solvent characteristics in triaxial electrospun fiber formation. React Funct Polym.2015;90:36-46.

[29] GAUTAM S, DINDA AK, MISHRA NC. Fabrication and characterization of PCL/gelatin composite nanofibrous scaffold for tissue engineering applications by electrospinning method.Mat Sci Eng C.2013;33(3):1228-1235.